Varun Saxena, MD

Kaiser Permanente Researcher Profiles

Saxena, Varun

Publications

IFNL4 Genotype and Other Personal Characteristics to Predict Response to 8-Week Sofosbuvir-Based Treatment for Chronic Hepatitis C

Authors: O'Brien, Thomas R;Witt, David J;Saxena, Varun;Morrissey, Kerry Grace;Chen, Sabrina;Baker, Francine S;Prokunina-Olsson, Ludmila;Pfeiffer, Ruth M;Lai, Jennifer B

J Infect. 2024 Nov;89(5):106258. Epub 2024-08-30.

PubMed abstract

Survival Outcomes Among Patients With Hepatocellular Carcinoma in a Large Integrated US Health System

Authors: Yilma, Mignote;Houhong Xu, Richie;Saxena, Varun;Muzzin, Monica;Tucker, Lue-Yen;Lee, Jeffrey;Mehta, Neil;Mukhtar, Nizar

JAMA Netw Open. 2024 Sep 03;7(9):e2435066. Epub 2024-09-03.

PubMed abstract

Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease

Authors: Rodriguez, Luis A;Schmittdiel, Julie A;Liu, Liyan;Macdonald, Brock A;Balasubramanian, Sreepriya;Chai, Krisna P;Seo, Suk I;Mukhtar, Nizar;Levin, Theodore R;Saxena, Varun

JAMA Netw Open. 2024 Jul 01;7(7):e2421019. Epub 2024-07-01.

PubMed abstract

Implementation of a hepatocellular carcinoma surveillance program in a community-based integrated health system in patients with hepatitis C cirrhosis

Authors: Bui, Hien;Kumar, Nikhilesh G;Singal, Amit G;Boparai, Jasdeep;Tran, Don;Mukhtar, Nizar A;Saxena, Varun;Balasubramanian, Sripriya

Am J Gastroenterol. 2024 Feb 09.

PubMed abstract

Primary Care Utilization, Preventative Screening, and Control of Metabolic Syndrome in Metabolic Dysfunction-Associated Steatohepatitis Liver Transplant Recipients

Authors: Flynn, Sarah J;Saxena, Varun;Brandman, Danielle

J Prim Care Community Health. 2024 Jan-Dec;15:21501319241247974.

PubMed abstract

Comparing the Risk of Poor Outcomes Among Hepatitis C-Infected, Cured, and Never-Infected Controls

Authors: Saxena, Varun;Wu, Weilu;Balasubramanian, Sreepriya;Mukhtar, Nizar;Seo, Suk I;Ready, Joanna B;MacDonald, Brock A;Schmittdiel, Julie A

Gastro Hep Adv. 2024;3(6):871-879. Epub 2024-05-15.

PubMed abstract

AFP-L3 and DCP are superior to AFP in predicting waitlist dropout in HCC patients: Results of a prospective study

Authors: Mehta, Neil;Kotwani, Prashant;Norman, Joshua;Shui, Amy;Li, Po-Yi;Saxena, Varun;Chan, Wesley;Yao, Francis Y

Liver Transpl. 2023 Oct 01;29(10):1041-1049. Epub 2023-04-27.

PubMed abstract

Related Stories

Many adults may be unaware that they have liver disease

Many adults may be unaware that they have liver disease

January 31, 2025

Kaiser Permanente study suggests less than 1% of adults with MASLD may know that they have the condition.
New clinical tool can help identify patients at high risk for liver cancer

New clinical tool can help identify patients at high risk for liver cancer

July 11, 2024

Kaiser Permanente researchers have developed a liver cancer prediction model for patients with metabolic dysfunction-associated liver disease.
Antiviral medications that treat hepatitis C improve long-term outcomes

Antiviral medications that treat hepatitis C improve long-term outcomes

June 17, 2024

New Kaiser Permanente study identifies some patients cured of hepatitis C who may not require semi-annual surveillance for liver cancer.
Our Team
Back To Top